CA2484244A1 — Stable cytochrome p450 24 (cyp24) expressing cell line and methods and uses thereof
Assigned to Cytochroma Inc · Expires 2003-11-13 · 23y expired
What this patent protects
The invention relates to a stable recombinant host cell comprising a CYP24 nucleic acid. The host cell is preferably a mammalian cell or an insect cell . The cell is useful for identifying modulators of CYP24 that can be used in t he treatment of CYP24 expression - related medica…
USPTO Abstract
The invention relates to a stable recombinant host cell comprising a CYP24 nucleic acid. The host cell is preferably a mammalian cell or an insect cell . The cell is useful for identifying modulators of CYP24 that can be used in t he treatment of CYP24 expression - related medical conditions.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.